Figure 4.
(A) Comparison of pre- and post-treatment phase regardless of treatment. Patients (n = 13) showed significant drops in heart rate levels in the post-treatment phase (p < 0.001). The black line shows the control data collected at baseline, in order to provide a reference for the effect magnitude. (B) Effect in all responders independent from treatment (ketamine or placebo). (C) Effect in all non-responders independent from treatment (ketamine or placebo).
